Precision and ‘augmented’ medicine aim to push the limits of the current system, improve the patient’s life by personalizing their treatment and their care pathway. Thanks to TECHNION FRANCE, G9+ and GP24, on February 6, 2023, this joint event was held in the Salons des Arts et Métiers. AMASYNG wished to participate.
The event brought together entrepreneurs, doctors, investors, start-ups, large groups, as well as researchers from TECHNION, Israel Institute of Technology Research University.
PLENARY INTRODUCTION
Emmanuel Bacry, CNRS Senior Researcher, Health Data Hub Scientific Advisor
Alain Toledano, Oncologist, Director of Integrative Health Chair CNAM (Conservatoire National des Arts et Métiers), President and co-founder of the Rafael Institute.
ROUND TABLE N°1: AI & PRECISION MEDICINE
Joachim Behar, Director of TERA, a joint initiative between the Technion and Rambam Hospital. It combines clinical expertise, basic science and engineering in the fight against disease using large sets of medical data and the most recent advances in AI.
Barbara Boukobza, Radiologist associated with the CSE – Imaging Excellence Group
Alban Arrault, Data & AI Program Director, Servier
Yedidia Levy-Zauberman, Senior Vice President Public Affairs & Impact, Owkin
Maximilien Levesque, CEO and co-founder, Aqemia
ROUND TABLE N°2: AI & AUGMENTED MEDICINE
Elsy Boglioli, Founder and Director, Bio-up
Simon Turner, Partner, Sofinnova Partners
Pierrick Arnal, Scientific Director, Dreem
Lloyd Diamond, CEO, Pixium Vision
Thomas Serval, CEO, Baracoda
Elie Lobel, CEO, Rdsdiag